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Abstract
 
Rosacea is a very common skin disorder in the clinical practice that primarily affects the convex 
areas of the face. Extrafacial rosacea lesions have occasionally been described, but extensive 
involvement is exceptional. In the absence of its typical clinical or histological features, the 
diagnosis of extrafacial rosacea may be problematic. We describe an unusual case of rosacea 
with very exuberant extrafacial lesions, when compared with the limited involvement of the face.
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Introduction
 
Rosacea is a skin disorder frequently observed in the clinical
practice. It is characterized by the primary involvement of
convex areas of the face.
 
1
 
 However, a wide spectrum of clin-
ical findings is often observed.
 
2
 
 We describe an unusual case
of rosacea with exuberant extrafacial involvement.
 
Case Report
 
A 53-year-old man presented with an extensive exudative
exanthema consisting of papules and erythematous nodules,
pustules, and large granulomatous, nodulo-cystic lesions involv-
ing the face, neck, and upper chest, and extending from the
left shoulder along the whole left arm (Fig. 1). The dermatosis
relatively spared the central region of the face, being more
exuberant in its lateral aspects and ears. On the upper half of
the chest and the left arm (external aspect) the lesions were
densely confluent, very inflammatory and exudative, with a
crusty surface (Fig. 2). The lesions were pruritic only after sun
exposure. The dermatosis had about 6 years of evolution,
always localized to the face. The patient reported exacerba-
tion of the lesions, which extended to the chest and left arm,
in the past 2 months, following a period of mourning for the
death of a member of his family. At this time, he was medi-
cated with oral prednisolone, with transitory improvement of
the lesions followed by severe exacerbation. Subsequently,
admitting the clinical diagnosis of pustular dermatophytosis,
the patient was medicated with itraconazol, with continued
worsening of the cutaneous lesions. He had no other patho-
logical antecedents of interest and the remaining physical
examination was normal.
Bacteriological and mycological tests of the contents of
the pustules were negative. Baseline investigations, including
complete blood count, liver and renal functions, autoimmune
screen, serology for human immunodeficiency virus, and urine
bromides and iodides levels were negative or normal. Photo-
testing with ultraviolet A (100 J/cm
 
2 
 
daily) and ultraviolet B
(1,5 MED daily) failed to induce the clinical lesions. Histological
examination of a lesional biopsies fromy, the face and upper
arm, revealed the same features: slight irregular acanthosis,
polymorphous inflammatory infiltrate, and formation of
epithelioid granulomas in the superficial dermis, and concomi-
tant inflammation of the acute type with formation of follicular
pustules (Fig. 3). These findings were consistent with the clinical
diagnosis of rosacea. The presence of 
 
Demodex folliculorum
 
was not noticed.
The patient was treated with deflazacort 30 mg (3 weeks),
azithromycin (500 mg, 3 days a week, for 4 weeks), and
isotretinoin (10 mg daily, for 1 year, with gradual reduction
of the dose in the last months). He was instructed to avoid
sun exposure, and a titanium dioxide- and zinc oxide-based
sunscreen was prescribed. Gradual resolution of the lesions
occurred. One year later, there was still some facial erythema,
but complete resolution was achieved on the chest, left shoulder
and arm (Fig. 4).
 
Comment
 
Usually rosacea is a straightforward diagnosis. However, in
the absence of its typical clinical or histological features, the
diagnosis of extrafacial rosacea may be problematic. Initially,
the clinical differential diagnosis suggested were the many
subtypes of infectious folliculitis such as dermatophytosis,
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bacterial folliculitis, demodicosis or inflammatory folliculitis,
namely, actinic superficial folliculitis, eosinophilic pustular
folliculitis, iododerma, or bromoderma. The diagnosis of
infectious folliculitis and eosinophilic pustular folliculitis was
excluded by the clinical history, bacteriological and mycolog-
ical tests, and biopsy. Rare patients with actinic superficial
folliculitis develop sterile pustules 24–36 h following intense
sunlight exposure, with good response to isotretinoin.
 
3,4
 
 On
the contrary, the dermatosis described in our patient showed
gradual progression with asymmetric distribution, was not
triggered or maintained by sunlight or heat (just caused pruritus
with sun) and, inclusively, the phototesting was negative. The
patients with halogenoderma (iododerma or bromoderma)
tend to develop indurated pustulonodular lesions on the face
and extremities, after longer exposure to higher amount of
iodides or bromides. Our patient denied ingestion of medications
and a measure urine bromides and iodides level was negative.
Figure 1 Clinical features of the lesions, with extensive 
extrafacial involvement
Figure 2 Detail of the lesions on the left forearm
Figure 3 Formation of follicular pustules (hematoxylin and 
eosin, ×100)
Figure 4 Complete resolution of the lesions after one year of 
treatment with isotretinoin
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Therefore, in this case, the presence clinically of inflammatory
papules, pustules, and nodules on a congestive background,
with spread from the typical midfacial involvement to other
areas of the body, and the presence of poorly organized epi-
thelial granulomas and follicular pustules in the biopsy allow
the diagnosis of extrafacial rosacea.
Rosacea is a common skin disorder that is generally local-
ized to the face, more frequently affecting the nose, cheeks,
chin, forehead, and glabela, typically sparing the periocular
and perioral regions.
 
2
 
 The presence of rosacea with extrafacial
location has been occasionally reported.
 
5–7
 
 Extrafacial lesions
usually complicate the more serious cases of rosacea but,
occasionally, as was the case of our patient, they may accom-
pany slight facial lesions. Involvement of the lateral contours
of the face, ears, scalp (particularly in old patients), and neck
occurs mainly in erythematotelangiectatic rosacea.
 
2
 
 These
extrafacial manifestations are relatively uncommon and
generally arise in areas of chronic solar lesions or flushing.
 
8
 
Involvement, by acneiform-like lesions, of the chest, axillae,
shoulders, arms, and legs (thighs and knees) is described in the
literature, but is quite exceptional and generally occurs in the
context of the granulomatous variant of rosacea,
 
5,9,10
 
 as observed
in our patient.
Granulomatous rosacea is a variant characterized by
papules and monomorphic nodules with erythematous or
brownish tonality, generally with periorificial location.
 
1
 
 Usually,
the patient does not have persistent facial erythema.
 
10
 
 In an
anatomoclinical review of 53 cases of granulomatous rosa-
cea, extrafacial lesions were found in 15% of the patients.
 
11
 
The authors noticed the presence of those lesions mainly in
areas rich in apocrine and pilosebaceous glands, which led
them to the conclusion that there is a relationship between
granulomatous rosacea and other acneiform eruptions, such
as supurative hidrosadenitis.
 
11
 
The cause for the formation of granulomas in rosacea is
still unclear. They arise as local macrophage proliferation in
response to a persistent antigen, hence, the suggestion by many
authors as to the pathogenic role of 
 
Demodex folliculorum
 
.
 
12
 
Ayres,
 
9
 
 for instance, considers extrafacial rosacea to be caused
by a disseminated infestation by 
 
D. folliculorum
 
, normally
inhabiting follicles and sebaceous glands. However, follicular
inflammation may be observed in the absence of parasites,
and parasites may be observed without associated inflamma-
tion.
 
5,10
 
 A limitative factor in these studies has to do with the
fact that 
 
D. folliculorum
 
 is not easily detected in histological
preparations: the skin biopsy only shows the parasites that
reside superficially in the follicle, but not those located deeper
in the follicle or the parasite of 
 
Demodex brevis
 
 residing in
sebaceous glands.
 
2
 
Concerning the treatment, we opted for the use of very low
doses of isotretinoin (10 mg/day), regardless of body weight,
for a long period, with the gradual reduction of the dose to 3–
5 days a week. Some studies have established the safety and
efficacy of this type of therapeutic approach in difficult cases
of rosacea.
 
13,14
 
 In the long term, cumulative doses above
1075 mg/kg have not caused significant radiological changes.
 
15
 
In our patient, the annual cumulative dose is, on average,
much lower than that (i.e. 60 mg/kg). The benefit of concom-
itant short-term corticotherapy has been reported, particularly
for granulomatous rosacea.
 
10
 
 Thus, we also combined
isotretinoin with oral corticoids in the first 3 weeks of
treatment with good results. In the first month of treatment
we also used, azithromycin 3 days a week, in accordance with
recent studies that demonstrated the efficacy and safety of this
antibiotic in the management of rosacea.
 
16,17
 
Reports of extrafacial rosacea are rather scarce. However,
it may be more common than it is thought, because it is gen-
erally not considered and/or not researched. We presented an
unusual setting of extrafacial rosacea that is remarkable for
the exuberant and extensive involvement, when comparing
with facial involvement, the initial diagnostic difficulty and
the good therapeutic results obtained. This case leaves a number
of questions for further study, namely, the potential of extra-
facial symptoms in rosacea, the sensitivity to sunlight, the psy-
chogenic factors, and the hypothetical role of 
 
D. folliculorum
 
.
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